Skip to content
Unrated Drug recall · FDA · Published July 25, 2025

Alembic Doxepin Capsules Recall: Nitrosamine Impurity Risk

Alembic Pharmaceuticals recalls 10mg Doxepin capsules due to nitrosamine impurity exceeding safety limits. This prescription drug may pose health risks if consumed. Consumers should contact the manufacturer for details.

🇺🇸 FDA recall #D-0566-2025DrugAlembic ›
Take action

Contact the company

Recalling firmAlembic Pharmaceuticals LimitedFormulation Division, Village Panelav, P.O. Tajpura, Near Baska, Taluka Halol · Panchmahal, India
✎ GovInfoNow plain-language explainer

Alembic Pharmaceuticals is recalling 10mg Doxepin Hydrochloride capsules because they contain a harmful nitrosamine impurity above safety limits. This could pose health risks if taken as prescribed. Read more at govinfonow.com/recall/31956-alembic-doxepin-capsules-recall-nitrosamine-impurity-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/31956-alembic-doxepin-capsules-recall-nitrosamine-impurity-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0566-2025

Cite this page

“Alembic Doxepin Capsules Recall: Nitrosamine Impurity Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31956-alembic-doxepin-capsules-recall-nitrosamine-impurity-risk. Based on FDA recall #D-0566-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0566-2025%22&limit=1).

Alembic Pharmaceuticals Limited voluntarily recalled Doxepin Hydrochloride Capsules, USP, 10 mg, following CGMP deviations involving a nitrosamine impurity above the proposed interim limit, according to the FDA on July 25, 2025.

How to tell if you have it

  • Brand: Alembic
  • Product: Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules
  • NDC: 62332-637-31
  • Lot: 2305015142
  • Exp. Date: 9/30/2025

The hazard

The recall addresses CGMP deviations due to the presence of a nitrosamine drug substance related impurity above the proposed interim limit, according to the FDA.

Context

GovInfoNow's records show Alembic Pharmaceuticals Limited has 6 other recalls on record since June 10, 2020. Other recent recalls of similar products include Asclemed Duloxetine Capsules Recall: Nitrosamine Impurity Risk (May 14, 2026), Appco Pharma Prazosin Capsules Recall: Nitrosamine Impurity Risk (March 27, 2026), and Zydus Clomipramine Capsules Recall: Nitrosamine Impurities Risk (October 22, 2025).

How to tell if you have this one

Check for the product name 'Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules' with NDC code 62332-637-31 and lot number 2305015142. These were manufactured in India and distributed in the US by Alembic Pharmaceuticals.

  • Brand
    Alembic
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the NDC code 62332-637-31 and lot number 2305015142 on the packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 19 days after the firm started it.

1. Firm started the recall: Jul 25, 202512. FDA classified it Class II: Aug 1, 202523. Published in FDA’s Enforcement Report: Aug 13, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the expiration date?

The expiration date for the recalled capsules is September 30, 2025.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0566-2025 (July 25, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0566-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA